Summary
Stimulation-evoked tritium overflow was examined in superfused rat brain cortex slices (stimulus: electrical impulses; 3 Hz) and synaptosomes (stimulus: potassium 12 mmol/l) preincubated with 3H-5-HT. 1. In slices and synaptosomes, the evoked 3H overflow was facilitated by forskolin and 8-Br-cAMP, but was not affected by AH 21-132 (an inhibitor of cAMP phosphodiesterase; cis-6-(p-acetamidophenyl)-1, 2, 3, 4, 4 a,10b-hexahydro-8, 9-dimethoxy-2-methylbenzo [c] [1,6]-naphthyridine). In the presence of AH 21-132, the facilitatory effect of forskolin on evoked overflow was increased. 2. In slices, AH 21-132 or combined administration of forskolin plus AH 21-132 did not change the percentage of basal or evoked 3H overflow represented by unmetabolized 3H-serotonin (about 30% and 60%, respectively). 3. In slices, cocaine or 6-nitroquipazine, an inhibitor of serotonin uptake, did not influence the increase in evoked overflow produced by forskolin plus AH 21-132. Forskolin plus AH 21-132 did not alter the inhibitory effect of serotonin (examined in the presence of 6-nitroquipazine) and the facilitatory effect of metitepin (a serotonin receptor antagonist) on evoked 3H overflow, but considerably decreased the inhibitory effect of clonidine or B-HT 920 (2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo-[5,4-d]-azepine). The present results suggest that the serotoninergic nerve terminals in the rat brain cortex are endowed with an adenylate cyclase, which is negatively coupled to the presynaptic α2-adrenoceptors, but is not linked to the presynaptic autoreceptors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Classen K, Göthert M, Schlicker E (1984) Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine. Naunyn-Schmiedeberg's Arch Pharmacol 326:198–202
De Vivo M, Maayani S (1986) Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J Pharmacol Exp Ther 238:248–253
Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptc 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1–7
Exton JH (1985) Mechanisms involved in α-adrenergic phenomena. Am J Pbysiol248:E633-E647
Göthert M (1980) Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 314:223–230
Göthert M (1982) Modulation of serotonin release in the brain via presynaptic receptors. Trends Pharmacol Sci 3:437–440
Göthert M (1985) Role of autoreceptors in the function of the peripheral and central nervous system. Arzneim Forsch 35:1909–1916
Göthert M, Hentrich F (1984) Role of cAMP for regulation of impulse-evoked noradrenaline release from the rabbit pulmonary artery and its possible relationship to presynaptic ACTH receptors. Naunyn-Schmiedeberg's Arch Pharmacol 328:127–134
Göthert M, Weinheimer G (1979) Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 310:93–96
Graefe KH, Stefano FJE, Langer SZ (1973) Preferential metabolism of (−)-3H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol 22:1147–1160
Limbird LE, Sweatt JD (1985) Alpha-adrenergic receptors - apparent interaction with multiple effector systems. In: Conn PM (ed) Receptors, vol II. Orlando. Academic Press, pp 281–305
Markstein R, Digges K, Marshall NR, Starke K (1984) Forskolin and the release of noradrenaline in cerebrocortical slices. Naunyn-Schmiedeberg's Arch Pharmacol 325:17–24
Markstein R, Hoyer D, Engel G (1986) 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 333:335–341
Metzger H, Lindner E (1981) The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneim Forsch 31:1248–1250
Moret C (1985) Pharmacology of the serotonin autoreceptor. In: Green AR (ed) Neuropharmacology of serotonin. Oxford New York Toronto Melbourne, Oxford University Press, pp 21–49
Mulder AH, Schoffelmeer ANM (1985) Catecholamine and opioid receptors, presynaptic inhibition of CNS neurotransmitter release, and adenylate cyclase. In: Cooper DMF, Seamon KB (eds) Advances in cyclic nucleotide and protein phosphorylation research, vol 19. New York, Raven, pp 273–286
Mulder AH, van den Berg WB, Stoof JC (1975) Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system. Brain Res 99: 419–424
Mulder AH, Frankhuyzen AL, Stoof JC, Wemer J, Schoffelmeer ANH (1984) Catecholamine receptors, opiate receptors, and presynaptic modulation of neurotransmitter release in the brain. In: Catecholamines: neuropharmacology and central nervous system — theoretical aspects. Alan R. Liss, New York, pp 47–58
Sachs L (1974) Angewandte Statistik, 4th edn. Springer, Berlin Heidelberg New York
Schlicker E, Classen K, Göthert M (1984) Evidence against coupling of presynaptic serotonin autoreceptors in rat brain to an adenylate cyclase. IUPHAR 9th International Congress of Pharmacology, London, 1984, Abstract 2050P
Schlicker E, Fink K, Göthert M (1987) Influence of eicosanoids on serotonin release in the rat brain: inhibition by prostaglandins E1 and E2. Naunyn-Schmiedeberg's Arch Pharmacol 335: 646–651
Schoffelmeer ANM, Wardeh G, Mulder AH (1985) Cyclic AMP facilitates the electrically evoked release of radiolabelled noradrenaline, dopamine, and 5-hydroxytryptamine from rat brain slices. Naunyn-Schmiedeberg's Arch Pharmacol330: 74–76
Seamon KB, Daly JW (1981) Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem 256:9799–9801
Seamon KB, Daly JW (1983) Forskolin, cyclic AMP and cellular physiology. Trends Pharmacol Sci 4:120–123
Seamon KB, Vaillancourt R, Edwards M, Daly JW (1984) Binding of [3H] forskolin to rat brain membranes. Proc Natl Acad Sci US-Biol Sci 81:5081–5085
Starke K (1981) Presynaptic receptors. Annu Rev Pharmacol Toxicol 21:7–30
Steppeler A, Döring C, Hedler L, Starke K (1982) Effect of amezinium on the release and catabolism of 3H-monoamines in brain slices. Biochem Pharmacol 31:2395–2402
Vaatstra WJ, Deiman-van Aalst WMA, Eigeman L (1981) DU 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor. Eur J Pharmacol 70:195–202
Author information
Authors and Affiliations
Additional information
This study was supported by a grant of the Deutsche Forschungsgemeinschaft. Part of the present results was reported at the 9th International Congress of Pharmacology, London 1984 (Schlicker et al. 1984)
Send offprint requests to M. Göthert
Rights and permissions
About this article
Cite this article
Schlicker, E., Fink, K., Classen, K. et al. Facilitation of serotonin (5-HT) release in the rat brain cortex by cAMP and probable inhibition of adenylate cyclase in 5-HT nerve terminals by presynaptic α2-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 336, 251–256 (1987). https://doi.org/10.1007/BF00172674
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00172674